A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis.

@article{Kessel2014ASF,
  title={A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis.},
  author={Christoph Von Kessel and Kutty Selva Nandakumar and Francis B. Peters and Varun Gauba and Peter G. Schultz and Rikard Holmdahl},
  journal={Arthritis & rheumatology},
  year={2014},
  volume={66 3},
  pages={
          610-21
        }
}
OBJECTIVE A deficiency in C5 protects against arthritis development. However, there is currently no approach successfully translating these findings into arthritis therapy, as by targeting the key component, C5a. The aim of this study was to develop a vaccination strategy targeting C5a as therapy for patients with rheumatoid arthritis. METHODS An anti-C5a vaccine was generated by incorporating the unnatural amino acid p-nitrophenylalanine (4NPA) into selected sites in the murine C5a molecule… CONTINUE READING

Citations

Publications citing this paper.